Clinical Trial Update: Monotherapy With Rapamycin in Long-standing Type 1 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 trial assessing rapamycin monotherapy in long-standing Type 1 diabetes has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: Piemonti Lorenzo | Conditions: Diabetes Mellitus, Type 1 | Phase 2 | Status: COMPLETED